Showing results (461-470 of 3,286) with videos related to
Sort By:
Pageof 329
Metabolic Brain Disease|February 12, 2016
PPARδ agonist GW0742 ameliorates Aβ1-42-induced hippocampal neurotoxicity in miceYun-Qi An, Chun Teng Zhang, Yong Du, et al.Metabolic Brain Disease|January 20, 2016
The roles of CC2D1A and HTR1A gene expressions in autism spectrum disordersElif Funda Sener, Merve Cıkılı Uytun, Keziban Korkmaz Bayramov, et al.Metabolic Brain Disease|February 29, 2016
Meloxicam-loaded nanocapsules as an alternative to improve memory decline in an Alzheimer's disease model in mice: involvement of Na(+), K(+)-ATPaseFrancine R Ianiski, Catiane B Alves, Carla F Ferreira, et al.Metabolic Brain Disease|March 5, 2016
Time dependent impact of perinatal hypoxia on growth hormone, insulin-like growth factor 1 and insulin-like growth factor binding protein-3Ömer Kartal, Seçil Aydınöz, Ayşe Tuğba Kartal, et al.Metabolic Brain Disease|October 2, 2015
Memory deficits associated with khat (Catha edulis) use in rodentsS T Kimani, N B Patel, P G KioyMetabolic Brain Disease|January 16, 2015
Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approachesDominic Schomberg, Gurwattan Miranpuri, Tyler Duellman, et al.Metabolic Brain Disease|December 1, 1989
Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathyK D Mullen, J V Martin, W B Mendelson, et al.Metabolic Brain Disease|December 16, 2014
Electroacupuncture improves cognitive deficits associated with AMPK activation in SAMP8 miceWeiguo Dong, Wanqing Guo, Xuehua Zheng, et al.Metabolic Brain Disease|December 5, 2014
GC-MS-based plasma metabolomic investigations of morphine dependent rats at different states of euphoria, tolerance and naloxone-precipitated withdrawalRuoxu Liu, Jianhua Cheng, Jingwen Yang, et al.Metabolic Brain Disease|June 1, 1989
Loss of muscarinic cholinergic receptors from the temporal cortex of alcohol abusersG Freund, W E BallingerPageof 329